193 related articles for article (PubMed ID: 35749551)
1. Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
Zhou Z; Ge H; Li Y; Wang D; Güngör C
PLoS One; 2022; 17(6):e0270608. PubMed ID: 35749551
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
4. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
6. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
7. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
8. Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival.
Wilhelm A; Müller SA; Steffen T; Schmied BM; Beutner U; Warschkow R
J Gastrointest Surg; 2016 Feb; 20(2):401-10. PubMed ID: 26487334
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract][Full Text] [Related]
10. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
11. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Primary Tumor Resection for Metastatic Small Intestine Neuroendocrine Tumors and Survival: A Propensity Score-Matched Analysis.
Yan H; Yin L; Han H; Jin Y; Liu Z
J Invest Surg; 2022 Jun; 35(6):1239-1247. PubMed ID: 34991432
[TBL] [Abstract][Full Text] [Related]
13. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
14. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis.
Wilhelm A; Galata C; Beutner U; Schmied BM; Warschkow R; Steffen T; Brunner W; Post S; Marti L
J Surg Oncol; 2018 Mar; 117(3):397-408. PubMed ID: 29044591
[TBL] [Abstract][Full Text] [Related]
15. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
Tsilimigras DI; Hyer JM; Paredes AZ; Ejaz A; Cloyd JM; Beane JD; Dillhoff M; Tsung A; Pawlik TM
J Gastrointest Surg; 2021 Sep; 25(9):2368-2376. PubMed ID: 33403563
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran TB; Qadan M; Dua MM; Norton JA; Poultsides GA; Visser BC
Surgery; 2015 Aug; 158(2):486-93. PubMed ID: 26013988
[TBL] [Abstract][Full Text] [Related]
17. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
18. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
Wu L; Chen F; Chen S; Wang L
Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478
[TBL] [Abstract][Full Text] [Related]
19. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
[Next] [New Search]